No results found for “”
No results found for filter “”
-
Blog articles 21.11.19
Improving Outcomes for People with Diabetes: How Data, Access to Innovation and Rethinking Care Can Unleash...
Sharing solutions to a growing health crisis
Read Article -
Blog articles 20.11.19
Orphan drugs & paediatric medicines: how to deliver for children with rare diseases (Guest blog)
Incentives have increased the number of medicines for children with rare conditions – here’s how Europe can do even better
Read Article -
Statements & press releases 18.11.19
Calling on the EU to remain on the front line of the global battle against AMR – industry stands ready...
As we embark on World Antibiotic Awareness Week and European Antibiotic Awareness Day, EFPIA, Vaccines Europe, and their Members reiterate their commitment...
Read Article -
Statements & press releases 12.11.19
A wake-up call for HTA bodies and payers on assessing and valuing person-centered therapeutic innovations...
Person-centered therapeutic innovations can have a significant and tangible impact on patients’ quality of life, improve adherence and as a consequence...
Read Article -
Blog articles 07.11.19
“If you always do what you’ve always done, you’ll always get what you’ve always got”
We need to work together to ensure access to treatments today and develop the medicines of the future.
Read Article -
Blog articles 06.11.19
In a world of finite resources, we cannot afford an inefficient use of health spending
Around 10% of EU GDP is spent on healthcare; yet, as much as one-fifth is spent inefficiently, making no meaningful contribution to health outcomes.
Read Article -
Statements & press releases 05.11.19
Everybody believes in partnership. But you need a strong vision to make it happen.
“Solutions from the past are not working for the challenges of the future”.
Read Article -
Blog articles 31.10.19
#WeWontRest until we beat Alzheimer’s disease – together
Unlocking the mystery behind Alzheimer's disease and dementia and improving care for people require new types of partnership. As we navigate uncertain...
Read Article -
Blog articles 30.10.19
Is gene therapy the beginning of a revolution in medicine? (Guest blog)
Ever since the Human Genome Project started unravelling the mysteries of our genes in the 1990s, a lot of hope has been pinned on the potential of gene...
Read Article -
Blog articles 29.10.19
No one can win the fight against disease on their own (Guest blog)
We can no longer afford to have a narrow focus when the solutions that patients require call for a broad coalition of actors.
Read Article -
Statements & press releases 24.10.19
EFPIA position on clinical trial transparency
The biopharmaceutical industry believes that the disclosure of clinical trial results and appropriate sharing of clinical trial data is in the best interests...
Read Article -
Statements & press releases 24.10.19
The economy of well-being
EFPIA welcomes the Council Conclusions on the Economy of Wellbeing, aiming to put people and their wellbeing at the centre of policy-making
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 26.09.19
A European Cancer Plan: Make it disruptive!
Cancer patient outcomes vary widely across Europe – the European Health Forum Gastein will explore how to bring the best care to all
Read Article -
EFPIA News 11.09.19
Mission Letter from EU President-elect Ursula von der Leyen to Stella Kyriakides, Commissioner-designate...
We look forward to working with Commissioner Kyriakides and her team, as well as colleagues in Member States to ensure access and availability of new treatments...
Read Article -
EFPIA News 25.07.19
Unleashing the potential of data to improve cancer care
Report from the Oncology Data Summit
Read Article -
EFPIA News 25.07.19
A busy year, before a hectic autumn
Our Oncology Platform has tackled several topics from big data and AI to drug pricing and improving patient outcomes.
Read Article -
EFPIA News 06.02.19
Open Letter from EFPIA President Dr Stefan Oschmann on the SPC manufacturing waiver
For our sector, it is essential that Europe's world-class protection of intellectual property rights be guaranteed in future. We are deeply concerned that...
Read Article -
EFPIA News 26.09.18
The Value of Health: Improving Outcomes
More effective, patient-centred, and sustainable health systems: the benefits of health outcomes measurement
Read Article -
EFPIA News 07.08.18
Exploring the science and innovation behind #WeWontRest
A new partnership with ITN Productions
Read Article -
EFPIA News 26.06.18
Video and report of the Unlocking Tomorrow’s Cures Exhibition, 22-25 May 2018, European Parliament
The exhibition explored the cutting-edge science behind new treatments and how it is transforming patients’ lives.
Read Article -
EFPIA News 25.06.18
Apply now for the Health Collaboration Awards 2018
Submit a project by 21 September 2018
Read Article -
EFPIA News 08.05.18
EFPIA position on proposal for a Regulation of the European Parliament and the Council on HTA and amending...
This paper outlines EFPIA’s views on the four pillars of EU HTA cooperation included in the Commission proposal
Read Article -
EFPIA News 03.05.18
Early Career Research Prize in Vaccinology R&D – 2nd edition
Promote and foster a younger generation of scientists in the early stages of their career!
Read Article -
EFPIA News 03.07.17
EFPIA-College of Europe Prize
The 2017 Laureat of the EFPIA-College of Europe Prize is Luca Deplano
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 18.11.19
Calling on the EU to remain on the front line of the global battle against AMR – industry stands ready...
As we embark on World Antibiotic Awareness Week and European Antibiotic Awareness Day, EFPIA, Vaccines Europe, and their Members reiterate their commitment...
Read Article -
Statements & press releases 12.11.19
A wake-up call for HTA bodies and payers on assessing and valuing person-centered therapeutic innovations...
Person-centered therapeutic innovations can have a significant and tangible impact on patients’ quality of life, improve adherence and as a consequence...
Read Article -
Statements & press releases 05.11.19
Everybody believes in partnership. But you need a strong vision to make it happen.
“Solutions from the past are not working for the challenges of the future”.
Read Article -
Statements & press releases 24.10.19
EFPIA position on clinical trial transparency
The biopharmaceutical industry believes that the disclosure of clinical trial results and appropriate sharing of clinical trial data is in the best interests...
Read Article -
Statements & press releases 24.10.19
The economy of well-being
EFPIA welcomes the Council Conclusions on the Economy of Wellbeing, aiming to put people and their wellbeing at the centre of policy-making
Read Article -
Statements & press releases 23.10.19
Have your say and contribute to the strategic research agenda for a Public-Private Partnership for Health...
The goal is to create a unique platform that does not exist anywhere else, a European multi-sector Partnership for health innovation
Read Article -
Statements & press releases 20.09.19
EFPIA statement on Medicine Shortages in Europe
Drug shortages are a growing source of concern and industry is taking every possible step in our capacity to minimise the impact of shortages for patients....
Read Article -
Statements & press releases 16.09.19
93 European Associations call for an Ambitious Horizon Europe Programme
We are fully convinced that Europe has the potential to lead the global innovation race and to remain a model of economic and social prosperity. For that,...
Read Article -
Statements & press releases 12.09.19
Open letter to the Members of the European Parliament on the importance to sustain EU progress in fighting...
17 organisations active in human and animal health have sent an open letter to the Members of the European Parliament, urging them to bring antimicrobial...
Read Article -
Statements & press releases 10.09.19
Driving Health and Growth; A call for an industrial strategy for Europe
Five areas where policy makers can take action to drive Europe’s health and growth
Read Article -
Statements & press releases 09.07.19
EFPIA, EATRIS, ELIXIR, BBMRI, ECRIN statement on the role of research infrastructures to boost patient-centred...
Academia and research-intensive health industries need a vibrant, world-class, inter-connected health and research ecosystem to effectively translate ideas...
Read Article -
Statements & press releases 02.07.19
Value-based healthcare – an EFPIA perspective
How should the "value" in value-based healthcare be defined, how can a value-based approach help European health systems become more effective, accessible...
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 21.11.19
Improving Outcomes for People with Diabetes: How Data, Access to Innovation and Rethinking Care Can Unleash...
Sharing solutions to a growing health crisis
Read Article -
Blog articles 20.11.19
Orphan drugs & paediatric medicines: how to deliver for children with rare diseases (Guest blog)
Incentives have increased the number of medicines for children with rare conditions – here’s how Europe can do even better
Read Article -
Blog articles 07.11.19
“If you always do what you’ve always done, you’ll always get what you’ve always got”
We need to work together to ensure access to treatments today and develop the medicines of the future.
Read Article -
Blog articles 06.11.19
In a world of finite resources, we cannot afford an inefficient use of health spending
Around 10% of EU GDP is spent on healthcare; yet, as much as one-fifth is spent inefficiently, making no meaningful contribution to health outcomes.
Read Article -
Blog articles 31.10.19
#WeWontRest until we beat Alzheimer’s disease – together
Unlocking the mystery behind Alzheimer's disease and dementia and improving care for people require new types of partnership. As we navigate uncertain...
Read Article -
Blog articles 30.10.19
Is gene therapy the beginning of a revolution in medicine? (Guest blog)
Ever since the Human Genome Project started unravelling the mysteries of our genes in the 1990s, a lot of hope has been pinned on the potential of gene...
Read Article -
Blog articles 29.10.19
No one can win the fight against disease on their own (Guest blog)
We can no longer afford to have a narrow focus when the solutions that patients require call for a broad coalition of actors.
Read Article -
Blog articles 23.10.19
MSD Policy Passport on Pharmaceutical Innovation (Guest blog)
Creating better understanding about the complex world of pharmaceutical innovation
Read Article -
Blog articles 21.10.19
Living with rare disease: hope for the future, access today
#WeWontRest until we make treatment for rare diseases less rare
Read Article -
Blog articles 17.10.19
Innovation challenge: You can't do it alone
On 14 August, the TB Alliance, a “not-for-profit organization dedicated to the discovery, development and delivery of better, faster-acting and affordable...
Read Article -
Blog articles 10.10.19
Analysis: Would ‘Medicines for the Many’ lead to many medicines?
Guest blog from Richard Torbett of ABPI on medicines access and availability in the UK
Read Article -
Blog articles 10.10.19
How big is the need for cross-border access to clinical trials? (Guest blog)
Patients with rare tumours and other rare diseases are particularly in need for treatment options. In some cases, these can be found in other countries....
Read Article